阿加曲班(MCI-9038), 凝血酶抑制剂

CAS: 74863-84-6 货号: A408293 分子式: C23H36N6O5S 分子量: 508.63 EC号: 638-764-8
有货
级别和纯度: Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 10mM in DMSO
储存条件
-80℃储存
运输条件
特低温运输
★
规格
库存
价格
数量
1ml
A408293-1ml
现货 Stock Image
¥836.90
请输入您要添加的产品数量

概述

Argatroban 是一种抗凝血剂,是一种直接的小分子凝血酶抑制剂。A peptidomimetic small molecule anticoagulant and direct thrombin inhibitor.

Information

Argatroban (MCI-9038) Argatroban (MCI-9038) is a potent and selective synthetic thrombin inhibitor with K i ranging from 5 nM to 39 nM, used as an anticoagulant.
In vitro

Argatroban is a potent and selective synthetic thrombin inhibitor with Ki values against thrombin ranging from 5 nM to 39 nM. Argatroban has antithrombotic properties in a wide variety of animal models of both platelet-rich and erythrocyte-rich thrombosis. Argatroban dose-dependently prevents thrombus formation with an estimated ED50 of 125 μg/kg in this test. Argatroban produces a dose-dependent increases in the thrombin time with a 511% increase at the highest dose used with only a 73% increase in the APTT at this dose. Argatroban can directly induce phenotype conversion of vascular smooth muscle cells with the resultant up-regulation of SMemb, PAI-1, and beta-actin mRNAs.

In vivo

Argatroban inhibits the formation of microthrombi up to 3 hours after middle cerebral artery (MCA) occlusion; beyond 3 hours, it is ineffective. Argatroban also significantly reduces the size of ischemic cerebral lesions at 6 hours after MCA occlusion. Argatroban (0.3 mg/h/rat) significantly decreases the number of microthrombi 1 day after distal middle cerebral artery (dMCA) occlusion in the rat distal middle cerebral artery occlusion model. Argatroban (0.1 and 0.3 mg/h/rat) significantly reverses a decrease in regional cerebral blood flow (rCBF) 1 day after distal middle cerebral artery (dMCA) occlusion. Argatroban (0.3 mg/h/rat) also significantly reduces the size of the cerebral infarction.
Cell Data

cell lines:Normal human dermal fibroblasts, Scleroderma fibroblasts

Concentrations:

Incubation Time:

Powder Purity:≥99%

规格

规格或纯度
Moligand™, 10mM in DMSO
英文名称
Argatroban (MCI-9038)
生化机理
阿加曲班(MCI-9038)是一种强效的选择性合成凝血酶抑制剂,Ki值在 5 nM 至 39 nM 之间,可用作抗凝剂。
储存条件
-80℃储存
运输条件
特低温运输
作用类型
抑制剂
作用机制
凝血酶抑制剂
名称和识别符
EC号
638-764-8
分子类型
小分子
Isomeric SMILES
C[C@@H]1CCN([C@H](C1)C(=O)O)C(=O)[C@H](CCCN=C(N)N)NS(=O)(=O)C2=CC=CC3=C2NCC(C3)C
分子量
508.63
Reaxy-Rn
24866985
Reaxys-RN link address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=24866985&ln=

高级数据

产品属性
ALogP 1.3
关联靶点(人)
F2 Tclin 凝血酶原(Prothrombin) (24 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
化学和物理性质
溶解性
Solubility (25°C) In vitro DMSO: 100 mg/mL (127.38 mM); Ethanol: 100 mg/mL (127.38 mM); Water: 10 mg/mL (12.73 mM);
熔点
180°C
安全和危险性(GHS)
象形图
信号词
警告
危险声明

H227: 可燃液体

预防措施声明

P210: 远离热源,热表面,火花,明火和其他点火源。 - 禁止抽烟。

P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。

P370+P378: 火灾时:使用干砂、干粉或抗醇泡沫灭火。

P403+P235: 存放在通风良好的地方。保持低温。

P501: 将内容物/容器送到批准的废物处理厂处理

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:
此产品的引用文献
溶液计算器